Neurology
Academic Department
Overview
Affiliation
people
Research
administers grant
- A4-OLE - Anti-Amyloid Treatment in Asymptomatic Alzheimer''s Disease (A4) Open-Label Extension Study
- ADMdx Statement of Work
- ARCADIA CSI (Cognition and Silent Infarcts)
- ASPIRE-administrative-Yale, Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)
- ASPIRE-per pt-Cincinnati - Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)
- Alzheimer’s risk is higher in women: identification of female-specific bioenergetic targets
- Antithrombotic Therapy After Cryptogenic Stroke With Atrial Cardiopathy: ARCADIA
- Antithrombotic Therapy after Cryptogenic Stroke with Atrial Cardiopathy: ARCADIA
- CREST-H Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics
- Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
- Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)
- Clinical Research Training Scholarship in Multiple Sclerosis
- Examination of extracellular vesicles in patients with chronic active MS lesions
- Human Brain Cancer, Rather Than Brain Cancer Cells, on a Plate
- Identifying mechanisms of tissue injury in MS lesions: a multi-modality imaging approach
- Intracerebral Hemorrhage and Increased Risk of Arterial Thromboembolism
- Left Atrial AbNormality, ThromboEmbolism, and Race: Novel Risk Factors For Stroke
- Metformin in Alzheimer’s dementia Prevention (MAP)
- Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer''s
- NN110- A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson’s Disease
- Neuroenergetic Adaptations in Alzheimer''s Disease: Implications on Amyloid Burden and Cognition
- RECONFIG- REcovery of CONsciousness Following Intracerebral HemorrhaGe
- RESEARCH SERVICES AGREEMENT AMENDMENT No. 1
- Sex Differences in the Molecular Determinants of AD Risk and Responsiveness to Treatment
- Sex Differences in the Molecular Determinants of Alzheimer''s Disease Risk: Prodromal Endophenotype
- Sex Differences in the Molecular Determinants of Alzheimer’s Disease Risk
- StATins Use in intRacerebral hemorrhage patieNts (SATURN) “Study"
- Stroke Trials Network of Columbia and Cornell
- Supplement to Perimenopause in Brain Aging and Alzheimer''s Disease
- Tau PET Imaging for the USC Alzheimer''s Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”)
- Unrecognized Myocardial Infarction May Be A Novel Risk Factor For Ischemic Stroke